Registry for Cerebral Small Vessel Disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the clinical spectrum and natural progression of Cerebral Small Vessel Disease (CSVD) through a multicenter approach. It will assess clinical, genetic, and epigenetic features of patients diagnosed with CSVD, while also identifying independent imaging markers to enhance clinical management. The study will involve collecting data from patients who meet specific MRI criteria related to CSVD.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Sign informed consent.
2. Age\>18
3. At least one of the following CSVD MRI characteristics: ①recent small subcortical infarct;②lacune of presumed vascular origin;③white matter hypertensity of presumed vascular origin;④perivascular space;⑤cerebral microbleeds;⑥brain atrophy

Exclusion Criteria:

1. Unable to cooperate with inspectors
2. Non-vascular white matter lesions
3. Other cognitive diseases (such as alzheimer's disease, Parkinson's disease or thyroid disease)
4. Serious systemic illness, such as heart, liver, kidney disease or major mental illness
5. Contraindications for imaging examination

Where it's running

• Department of Neurology , First Affiliated Hospital Fujian Medical University
  Fuzhou, Fujian, China Recruiting

Study contacts

• Study coordinator: Bin Cai, PhD
• Email: caibin929@163.com
• Phone: 13338413842

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Can QSM MRI help tell MS from age-related brain changes in older adults

  This study tests whether an advanced MRI technique called QSM can better differentiate MS-related brain lesions from age-related or small vessel changes in people aged 50–70.

  Recruiting Oslo University Hospital · Oslo, Oslo · NCT07444047

• Registry for people with cerebral small vessel disease.

  This project will collect clinical information and MRI scans from people aged 50 and older with MRI signs of cerebral small vessel disease to see how the condition relates to thinking, walking, and daily function over time.

  Recruiting Dongzhimen Hospital, Beijing · Beijing, Beijing Municipality · NCT07342075

• Observing brain blood vessel health in a community

  This study looks at how blood vessel health in the brain is affected by conditions like high blood pressure and diabetes in adults aged 50-75 living in Beijing.

  Recruiting Beijing Tiantan Hospital · Beijing, Beijing Municipality and 1 other locations · NCT06579677

• Intermittent theta-burst brain stimulation to improve thinking in people with small vessel brain disease

  This trial will try intermittent theta-burst stimulation (a form of noninvasive brain stimulation) to see if it helps cognition in people aged 45–80 with vascular cognitive impairment from cerebral small vessel disease.

  Recruiting Beijing Tiantan Hospital · Beijing · NCT06579664

• Evaluating the effects of Calculus Bovis Sativus for ischemic cerebrovascular diseases

  This study is testing whether a traditional Chinese medicine called Calculus Bovis Sativus can help improve brain health and reduce inflammation in people with ischemic cerebrovascular diseases like stroke.

  Recruiting at 2 sites Tongji Hospital · Wuhan, Hubei and 1 other locations · NCT06474507

• Evaluating retinal health in patients with cerebral small vessel disease

  This study is testing if a special eye scan can help doctors understand how brain health is affected in older adults with cerebral small vessel disease.

  Recruiting Zhejiang Provincial People's Hospital · Hangzhou, Zhejiang · NCT06431711

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.